2004 KOSEF-JSPS Asian Science Seminar
Development of Mucosal Vaccines
From Basic Research to Clinical Application
INTERNATIONAL VACCINE INSTITUTE (IVI), Seoul, Korea
October 24-27th, 2004
AGENDA
Sunday, 24th October, 2004
16.00 – 18.00
Registration (Novotel Hotel)
18.00 – 20.00
Welcome to participants (Novotel Hotel)
Monday, 25th October, 2004
09.00 – 09.30
Opening remarks
Tadashi Yamamoto (University of Tokyo, Japan)
John D. Clemens (IVI, Korea)
Officers from KOSEF and JSPS
SESSION I
Basic Aspect of Mucosal Immune System
Chairperson : Aldo Tagliabue (IVI, Korea)
Tadashi Yamamoto (University of Tokyo, Japan)
09.30 – 10.00
Infectious diseases and their control: Past, present and future
Yoshifumi Takeda (Jissen Women’s University, Japan)
10.00 – 11.00
Uniqueness of mucosal immune system
Hiroshi Kiyono (University of Tokyo, Japan)
11.00 – 12.00
Role of costimulation in immunity
Byoung S. Kwon (University of Ulsan, Korea)
12.00 – 13.00
Lunch
SESSION II
Organogenesis of Mucosal Lymphoid Tissues
Chairperson : Byoung S. Kwon (University of Ulsan, Korea)
13.00 – 14.00
Lymphoid organogenesis
Martin Lipp (Max-Delbrück-Centre for Molecular Medicine, Germany)
14.00 – 15.00
Peyer’s patch organogenesis
Hisahiro Yoshida (RIKEN, Japan)
15.00 – 15.30
Coffee break
15.30 – 16.30
Antigen sampling and uptake in the mucosal tissues
Florence Niedergang (Institute Curie, France)
16.30 – 17.30
Functional development of intestinal immune surveillance
Hiromichi Ishikawa (Keio University, Japan)
17.30 – 18.00
Tour of IVI (guide by Dr. Aldo Tagliabue)
18.00 – 20.00
Dinner - Korean Barbecue (IVI lobby)
Tuesday, 26th October, 2004
SESSION III
Regulation of Mucosal Lymphocyte Homing
Chairperson : Masafumi Yamamoto (Nihon University, Japan)
09.00 – 10.00
Lymphocyte trafficking across high endothelial venules: dogmas and enigmas
Masayuki Miyasaka (Osaka University, Japan)
SESSION IV
Innate and Acquired Immunity in Mucosal Tissues
Chairperson : Masayuki Miyasaka (Osaka University, Japan)
10.00 – 11.00
TLRs for the mucosal immunity
Kiyoshi Takeda (Kyushu University, Japan)
11.00 – 12.00
Role of GALT for mucosal IgA immunity
Masafumi Yamamoto (Nihon University, Japan)
12.00 – 13.30
Lunch & preparation for poster presentation
SESSION V
Molecular and Cellular Aspect of Mucosal Infectious Diseases
Chairperson : Yoshifumi Takeda (Jissen Women’s University, Japan)
13.30 – 14.30
Molecular mechanism of Shigella infection
Chihiro Sasakawa (University of Tokyo, Japan)
14.30 – 15.30
Mucosal invasion by Salmonella
Ho Young Kang (Pusan National University, Korea)
15.30 – 16.00
Coffee break
16.00 – 17.00
Molecular aspects of influenza virus: exploiting genome packaging to develop
vaccines by reverse genetics
Taisuke Horimoto (University of Tokyo, Japan)
17.00 – 18.00
Perspectives of AIDS vaccine development
Young Chul Sung (Pohang University of Science & Technology, Korea)
18.00 – 20.00
Poster Presentation (IVI lobby)
2
Wednesday, 27th October, 2004
SESSION VI
New Trends in Mucosal Vaccine Development
Chairperson : Hiroshi Kiyono (University of Tokyo, Japan)
08.30 – 09.30
New TB vaccine strategies by the use of CD1 immunity
Masahiko Sugita (Kyoto University, Japan)
09.30 – 10.30
TB derived peptide 25 as a new immunomodulator
Kiyoshi Takatsu (University of Tokyo, Japan)
10.30 – 10.45
Coffee break
10.45 – 11.30
Bacterial enterotoxins as mucosal adjuvants
Mi-Na Kweon (IVI, Korea)
11.30 – 12.30
TLR-targeted mucosal adjuvant
Joon-Haeng Rhee (Chonnam National University, Korea)
12.30 – 13.30
Lunch
SESSION VII
From Laboratory Research to Field Trials
Chairperson : John D. Clemens (IVI, Korea)
13.30 – 14.00
From bench to bedside
John D. Clemens (IVI, Korea)
14.00 – 14.30
Field studies of the oral Cholera vaccine
Jacqueline Deen (IVI, Korea)
14.30 – 15.00
Role of field studies in developing Shigella vaccines
Lorenz von Seidlein (IVI, Korea)
15.00 – 15.30
Clinical trial of oral vaccine for Salmonella typhi
Aldo Tagliabue (IVI, Korea)
15.30 – 16.00
Coffee break
16.00 – 17.30
Round Table or Panel Discussion
“How can we bridge between the basic science in mucosal immunology and
translational research for field trials”
Chairperson : John D. Clemens (IVI, Korea)
Hiroshi Kiyono (University of Tokyo, Japan)
17.30 – 18.00
Summary and Conclusion
3